Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CAPR
CAPR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CAPR News
Capricor Executives Sell $1.46 Million in Shares Ahead of FDA Review
Jun 30 2026
stocktwits
Capricor Advances Biologics License Application for DMD Treatment
Jun 29 2026
NASDAQ.COM
Restaurant Brands International Options Volume Surges
Jun 26 2026
NASDAQ.COM
Capricor's Hope-2 Study Shows Stable Efficacy Over Five Years
Jun 26 2026
stocktwits
Capricor's Deramiocel BLA Under FDA Review for Duchenne Muscular Dystrophy
Jun 26 2026
NASDAQ.COM
Capricor's Biologics License Application Progress
Jun 26 2026
Newsfilter
Capricor Therapeutics Faces Stock Drop Ahead of FDA Advisory Meeting
Jun 26 2026
seekingalpha
Positive Five-Year Results for Deramiocel in DMD Study
Jun 26 2026
Newsfilter
Caprock Mining Closes $600,000 Financing Through Flow-Through Shares
Jun 19 2026
Yahoo Finance
FDA Reversal Sparks Biotech Comeback for UniQure and Peers
Jun 17 2026
seekingalpha
Capricor Sues Nippon Shinyaku Over DMD Therapy Distribution
Jun 17 2026
stocktwits
Capricor Therapeutics to Participate in Upcoming Investor Conferences
Jun 08 2026
Newsfilter
Capricor Therapeutics Q1 2026 Earnings Call Insights
May 13 2026
seekingalpha
Capricor Therapeutics to Announce Q1 Earnings on May 12
May 12 2026
seekingalpha
Capricor Executive Exercises Stock Options in $793K Transaction
May 10 2026
Fool
Krasney Sells Shares for Diversification Under 10b5-1 Plan
May 10 2026
NASDAQ.COM
Show More News